These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1670651)

  • 21. Reduction of intrahepatic vascular space in the pathogenesis of portal hypertension. In vitro and in vivo studies in the rat.
    Lee SS; Hadengue A; Girod C; Braillon A; Lebrec D
    Gastroenterology; 1987 Jul; 93(1):157-61. PubMed ID: 3582902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Doppler blood flow measurements in the portal system].
    Kalina Z; Scieszka J; Maślankiewicz A
    Pol Przegl Radiol; 1988; 52(6):284-6. PubMed ID: 3077452
    [No Abstract]   [Full Text] [Related]  

  • 23. Portal venous pressure and portasystemic shunting in experimental portal hypertension.
    Geraghty JG; Angerson WJ; Carter DC
    Am J Physiol; 1989 Jul; 257(1 Pt 1):G52-7. PubMed ID: 2750909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Localization of increased hepatic vascular resistance in liver cirrhosis.
    Shibayama Y; Nakata K
    Hepatology; 1985; 5(4):643-8. PubMed ID: 4018737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic hemodynamics and functions in extrahepatic portal obstruction in the rat with liver cirrhosis.
    Omokawa S; Saitoh H; Arai Y; Itoh M; Furuya T; Asanuma Y; Koyama K
    Hepatogastroenterology; 1991 Feb; 38(1):56-9. PubMed ID: 2026390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Establishment of a hepatic cirrhosis and portal hypertension model by hepatic arterial perfusion with 80% alcohol.
    Wang L; He FL; Liu FQ; Yue ZD; Zhao HW
    World J Gastroenterol; 2015 Aug; 21(32):9544-53. PubMed ID: 26327762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amiloride reduces portal hypertension in rat liver cirrhosis.
    Steib CJ; Hennenberg M; Beitinger F; Hartmann AC; Bystron M; De Toni EN; Gerbes AL
    Gut; 2010 Jun; 59(6):827-36. PubMed ID: 20551467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanical pumping of portal blood to the liver: hemodynamic effects of a new experimental treatment for portal hypertension.
    Bernadich C; Fernández M; Bandi JC; Bosch J; Rodés J
    J Hepatol; 1996 Jul; 25(1):98-105. PubMed ID: 8836908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic artery and portal vein vascularization of normal and cirrhotic rat liver.
    Kassissia I; Brault A; Huet PM
    Hepatology; 1994 May; 19(5):1189-97. PubMed ID: 8175141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of tumor necrosis factor, endothelin and nitric oxide on hyperdynamic circulation of rats with acute and chronic portal hypertension.
    Wang JJ; Gao GW; Gao RZ; Liu CA; Ding X; Yao ZX
    World J Gastroenterol; 2004 Mar; 10(5):689-93. PubMed ID: 14991939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noncirrhotic portal hypertension.
    Sarin SK; Kumar A
    Clin Liver Dis; 2006 Aug; 10(3):627-51, x. PubMed ID: 17162232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrahepatic modulation of portal pressure and its role in portal hypertension.
    Wheatley AM; Zhang X
    Digestion; 1998; 59(4):424-8. PubMed ID: 9693223
    [No Abstract]   [Full Text] [Related]  

  • 33. Gene transfer of the neuronal NO synthase isoform to cirrhotic rat liver ameliorates portal hypertension.
    Yu Q; Shao R; Qian HS; George SE; Rockey DC
    J Clin Invest; 2000 Mar; 105(6):741-8. PubMed ID: 10727442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Akt gene therapy for cirrhotic rats with portal hypertension].
    Huang FZ; Deng G; Liu XY; Luo CQ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 33(1):31-7. PubMed ID: 18245901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction.
    Moleda L; Trebicka J; Dietrich P; Gäbele E; Hellerbrand C; Straub RH; Sauerbruch T; Schoelmerich J; Wiest R
    Gut; 2011 Aug; 60(8):1122-32. PubMed ID: 21317421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of endothelin A receptor antagonist on hepatic hemodynamics in cirrhotic rats. Implications for endothelin-1 in portal hypertension.
    Takashimizu S; Kojima S; Nishizaki Y; Kagawa T; Shiraishi K; Mine T; Watanabe N
    Tokai J Exp Clin Med; 2011 Jul; 36(2):37-43. PubMed ID: 21769771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined hepatic vein, umbilicoportal vein, and superior mesenteric artery catheterization in portal hypertension: estimation of the portal fraction of total hepatic blood flow in cirrhotic patients.
    Huet PM; Lavoie P; Légaré A; Viallet A
    Yale J Biol Med; 1975 Mar; 48(1):55-66. PubMed ID: 1130101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Splenic Doppler impedance indices: influence of different portal hemodynamic conditions.
    Bolognesi M; Sacerdoti D; Merkel C; Gerunda G; Maffei-Faccioli A; Angeli P; Jemmolo RM; Bombonato G; Gatta A
    Hepatology; 1996 May; 23(5):1035-40. PubMed ID: 8621130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hemodynamic changes after combination operation in cirrhotic patients with portal hypertension].
    Liu JK
    Zhonghua Wai Ke Za Zhi; 1993 Apr; 31(4):203-6. PubMed ID: 8275832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Portal vein flow pattern in portal hypertension.
    Lunderquist A
    Clin Radiol; 1980 Jul; 31(4):395-415. PubMed ID: 6998637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.